Protection of mice from LPS-induced shock by CD14 antisense oligonucleotide

Acta Medica Okayama

Volumn 55, Issue 2, 2001, Pages 105-115

  Furusako, Shoji ^a,b   Takahashi, Tomohiro ^a   Mori, Sadao ^a   Takahashi, Yasuo ^a   Tsuda, Toshihiko ^a   Namba, Masayoshi ^b   Mochizuki, Hidenori ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

BCG (bacillus Calmette Guerin); Sepsis; TNF

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CD14 ANTIGEN; HYBRID PROTEIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; REPORTER GENE; SEPTIC SHOCK; SURVIVAL RATE;

ANIMALS; ANTIGENS, CD14; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENES, REPORTER; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDES, ANTISENSE; RECOMBINANT FUSION PROTEINS; SHOCK, SEPTIC; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035316568     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Stone R: Search for sepsis drugs goes on despite past failures. Science (1994) 264, 365-367.
2. Grau GE and Maennel DN: TNF inhibition and sepsis - sounding a cautionary note. Nat Med (1997) 3, 1193-1195.
3. Kielian LT and Blecha F: CD14 and other recognition molecules for lipopolysaccharide: A review Immunopharmacology (1995) 29, 187-205.
4. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ and Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (1990) 249, 1431-1433.
5. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL and Goyert SM: Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity (1996) 4, 407-414.
6. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K and Akira S: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity (1999) 11, 443-451.
7. Schwandner R, Dziarski R, Wesche H, Rothe M and Kirschning CJ: Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem (1999) 274, 17406-17409.
8. Dziarski R, Tapping RI and Tobias PS: Binding of bacterial peptidoglycan to CD14. J Biol Chem (1998) 273, 8680-8690.
9. Leturcq DJ, Moriarty AM, Talbott G, Winn RK, Martin TR and Ulevitch RJ: Antibodies against CDI4 protect primates from endotoxin-induced shock. J Clin Invest (1996) 98, 1533-1538.
10. Schimke J, Mathison J, Morgiewicz J and Ulevitch RJ: Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci USA (1998) 95, 13875-13880.
11. Frevert CW, Matute-Bello G, Skerrett SJ, Goodman RB, Kajikawa O, Sittipunt C and Martin TR: Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol (2000) 164, 5439-5445.
12. Amano S, Kawakami K, Iwahashi H, Kitano S and Hanazawa S: Functional role of endogenous CD14 in lipopolysaccharide-stimulated bone resorption. J Cell Physiol (1997) 173, 301-309.
13. Imai K, Takeshita A and Hanazawa S: Transforming growth factor-beta inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein I and CD14 receptor expression. Infect Immun (2000) 68, 2418-2423.
14. Crooke TS and Lebleu B: In vivo studies with phosphorothioate oligonucleotides: Rationale for systemic therapy; in Antisense Research and Applications, Iversen P ed, CRC Press, Florida (1993) pp 461-469.
15. Nasu N, Yoshida S, Akizuki S, Higuchi Y, Setoguchi M and Yamamoto S: Molecular and physiological properties of murine CD14. Int Immunol (1991) 3, 205-213.
16. Vogel SN, Moore RN, Sipe JD and Rosenstreich DL: BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies. J Immunol (1980) 124, 2004-2009.
17. Zhang DE, Hetherington CJ, Tan S, Dziennis SE, Gonzalez DA, Chen HM and Tenen DG: SPI is a critical factor for the monocytic specific expression of human CD14. J Biol Chem (1994) 269, 11425-11434.
18. 2) and self-complementary d(GGGAAXYTTCCC) containig deoxyinosine and other mismatched bases. Nucleic Acid Res (1986) 14, 7727-7736.
19. Oda Y, Uesugi S, Ikehara M, Kawase Y and Ohtsuka E: NMR studies for identification of dI: dG mismatch base-pairing structure in DNA. Nucleic Acid Res (1991) 19, 5263-5267.
20. Martin FH, Castro MM, Aboul-ela F and Tinoco I Jr: Base pairing involving deoxyinosine: Implications for probe design. Nucleic Acid Res (1985) 13, 8927-8938.
21. Kox WJ, Volk T, Kox SN and Volk HD: Immunomodulatory therapies in sepsis. Intensive Care Med (2000) 26, 124-128.
22. Frevert CW, Matute-Bello G, Skerrett SJ, Goodman RB, Kajikawa O, Sittipunt C and Martin TR: Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol (2000) 164, 5439-5445.
23. Su GL, Dorko K, Strom SC, Nussler AK and Wang SC: CD14 expression and production by human hepatocytes. J Hepatol (1999) 31, 435-442.
24. Decker K: Biologically active products of stimulated liver macrophage (Kupffer cells). Eur J Biochem (1990) 192, 245-261.
25. Fearns C, Kravchenko VV, Ulevitch RJ and Loskutoff DJ: Murine CD14 gene expression in vivo: Extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med (1995) 181, 857-866.
26. Hetherington CJ, Kingsley PD, Crocicchio F, Zhang P, Rabin MS, Palis J and Zhang DE: Characterization of human endotoxin lipopolysaccharide receptor CD14 expression in transgenic mice. J Immunol (1999) 162, 503-509.
27. Tamura Y, Higuchi Y, Kataoka M, Akizuki S, Matsuura K and Yamamoto S: CD14 transgenic mice expressing membrane and soluble forms: Comparisons of levels of cytokines and lethalities in response to lipopolysaccharide between transgenic and non-transgenic mice. Int Immunol (1999) 11, 333-339.
28. Hermann W: Bacterial CpG DNA activates immune cells to signal infectious danger; in Advances in Immunology, Vol 73, Dixon FJ ed, Academic Press, London (1999) pp 329-368.
29. Klinman DM, Verthelyi D, Takeshita F and Ishii KJ: Immune recognition of foreign DNA: A cure for bioterrorism? Immunity (1999) 11, 123-129.
30. Sparwasser T, Miethke T, Lipford G, Erdmann A, Hacker H, Heeg K and Wagner H: Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol (1997) 27, 1671-1679.
31. Krieg AM, Yi Ae-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, and Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 374, 546-549.